NAV: 13 Dec 2024 | ₹19.94 |
Min. SIP amount | Not Supported |
Rating | 2 |
Fund size | ₹162.05Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 30.7% | 16.2% | 18.2% |
Category average | NA | 41.2% | 19.8% | NA |
Rank with in category | NA | 14 | 11 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 13.34% |
Cipla Ltd. | Healthcare | Equity | 6.12% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.95% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.59% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.31% |
Divi's Laboratories Ltd. | Healthcare | Equity | 5.29% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 5.09% |
Lupin Ltd. | Healthcare | Equity | 3.75% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 2.89% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 2.77% |
Novo Nordisk A/S - ADR | Healthcare | Forgn. Eq | 2.71% |
AbbVie Inc | Healthcare | Forgn. Eq | 2.71% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.44% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.30% |
Mankind Pharma Ltd. | Healthcare | Equity | 2.01% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 1.95% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 1.89% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.80% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.67% |
Novartis AG | Healthcare | ADS/ADR | 1.61% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.57% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.48% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.34% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.29% |
Laurus Labs Ltd. | Healthcare | Equity | 1.29% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.23% |
Syngene International Ltd. | Healthcare | Equity | 1.17% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 1.03% |
Ajanta Pharma Ltd. | Healthcare | Equity | 1.02% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 1.01% |
Biocon Ltd. | Healthcare | Equity | 0.99% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.92% |
Gland Pharma Ltd. | Healthcare | Equity | 0.92% |
Stryker Corp | Healthcare | Forgn. Eq | 0.92% |
Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 0.88% |
Medtronic | Healthcare | Forgn. Eq | 0.86% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.86% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 0.83% |
Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.68% |
Global Health Ltd. | Healthcare | Equity | 0.67% |
Pfizer Ltd. | Healthcare | Equity | 0.53% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.51% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.29% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.28% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.17% |
Grail Inc | Healthcare | Forgn. Eq | 0.00% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | Not Supported |